Essential Info
Instructor Resources
Overview
This book introduces students to the growing research field of health economics. Rather than offer details about health systems around the world without providing a theoretical context, Health Economics combines economic concepts with empirical evidence to enhance readers’ economic understanding of how health care institutions and markets function. It views the subject in both microeconomic and macroeconomic terms, moving from the individual and firm level to the market level to a macroeconomic view of the role of health and health care within the economy as a whole.
The book includes discussion of recent empirical evidence on the U.S. health system and can be used for an undergraduate course on U.S. health economics. It also contains sufficient material for an undergraduate or masters course on global health economics, or for a course on health economics aimed at health professionals. It includes a chapter on nurses as well as a chapter on the economics of hospitals and pharmaceuticals, which can be used in master’s courses for students in these fields. It supplements its analysis with readings (both classic and current), extensive references, links to Web sites on policy developments and public programs, review and discussion questions, and exercises.
A Student Solutions Manual provides answers to the odd-numbered exercises. Separately, downloadable supplementary material for instructors includes answers to all exercises and slides that can be used for class presentation.
About the Authors
Frank Sloan is J. Alexander McMahon Professor of Health Policy and Management and Professor of Economics at Duke University. A leader in the field of health economics for more than thirty years, he is coauthor of The Price of Smoking (2004) and Medical Malpractice (2008) and coeditor of Incentives and Choices in Health Care (2008), all published by the MIT Press.
Chee-Ruey Hsieh is a Research Fellow at the Institute of Economics, Academica Sinica, Taiwan, and the coeditor of three previous books on the economics of health care.
Table of Contents
- Health Economics
- Health Economics
- By Frank A. Sloan and Chee-Ruey Hsieh
- The MIT Press
- Cambridge, Massachusetts • London, England
- ©
- 2012
- Massachusetts Institute of Technology
- All rights reserved. No part of this book may be reproduced in any form by any electronic or mechanical means (including photocopying, recording, or information storage and retrieval) without permission in writing from the publisher.
- MIT Press books may be purchased at special quantity discounts for business or sales promotional use. For information, please email special_sales@mitpress.mit.edu or write to Special Sales Department, The MIT Press, 55 Hayward Street, Cambridge, MA 02142.
- This book was set in Melior and MetaPlus by Toppan Best-set Premedia Limited. Printed and bound in the United States of America.
- Library of Congress Cataloging-in-Publication Data
- Sloan, Frank A.
- Health economics / Frank A. Sloan and Chee-Ruey Hsieh.
- p. cm.
- Includes bibliographical references and index.
- ISBN 978-0-262-01676-6 (hardcover : alk. paper)
- 1. Medical economics. I. Hsieh, Chee-Ruey. II. Title.
- RA410.S55 2012
- 338.4′73621—dc23
- 2011032823
- 10 9 8 7 6 5 4 3 2 1
- Brief Table of Contents
- Preface xxvii
- Acknowledgments xxxiii
- Chapter 1 Introduction and Overview 1
- Part I Demand for Health, Health Care, and Insurance 37
- Chapter 2 Health and Health Behaviors 39
- Chapter 3 Demand for Health Care Services 83
- Chapter 4 Demand for Private Health Insurance 127
- Part II Supply of Health Care Services and Insurance 169
- Chapter 5 The Market for Physicians’ Services 171
- Chapter 6 Hospitals 219
- Chapter 7 Quality of Care and Medical Malpractice 275
- Chapter 8 Nurses in Hospital and Long-Term Care Service 319
- Chapter 9 Pharmaceutical Manufacturers 367
- Chapter 10 The Supply of Private Health Insurance 417
- Part III Market Structure in the Health Care Sector 467
- Chapter 11 Private Financing of Health Care Services 469
- Chapter 12 Government Financing and Private Supply 503
- Chapter 13 Public Supply and Financing 563
- Part IV Performance of the Health Care Sector: Positive and Normative Aspects 615
- Chapter 14 Cost and Cost-Effectiveness Analysis 617
- Chapter 15 Measuring Benefits and Cost-Benefit Analysis 657
- Chapter 16 The Contribution of Personal Health Services to Longevity, Population Health, and Economic Growth 693
- Chapter 17 Frontiers of Health Economics 737
- Index 753
- Contents
- Preface xxvii
- Acknowledgments xxxiii
- Chapter 1 Introduction and Overview 1
- 1.1 Health Economics as a Field of Inquiry 2
- The Importance of Health Economics 2
- The Growth of Health Economics 3
- 1.2 Factors Accounting for the Growth of Health Economics 5
- Improvements in Health and Longevity 5
- Expansion of Health Sectors 8
- 1.3 Important Institutional Features of Health Care 10
- Health Insurance 11
- Externalities and Government Intervention in Health Care Services Provision 13
- Asymmetric Information between Consumers and Suppliers of Health Care and the Institutional Responses 15
- 1.4 Government Intervention in Health Care Markets 16
- Government’s Roles in Achieving an Equitable Distribution of Resources 17
- The Equity-Efficiency Quandary and Government’s Role 18
- Government’s Role in Correcting Market Failures 20
- 1.5 The Book’s Four Parts: A Road Map 21
- Structure of the Book 21
- Part I Demand for Health, Health Care Services, and Insurance 22
- Part II Supply of Health Care Services and Insurance 24
- Part III Market Structure in the Health Care Sector 28
- Part IV Performance of the Health Care Sector: Positive and Normative Aspects 30
- 1.6 Conclusion 32
- Key Concepts 32
- Review and Discussion Questions 32
- Exercises 33
- Online Supplemental Material 34
- Supplemental Readings 34
- References 34
- Part I Demand for Health, Health Care, and Insurance 37
- Chapter 2 Health and Health Behaviors 39
- 2.1 Rationality and Other Economic Assumptions 40
- 2.2 Health Production Functions 43
- The Concept 43
- Health Stocks and Flows 44
- 2.3 The Demand for Health: Health as a Capital Stock 44
- Evolution of a Person’s Health over Time 44
- Demand for Health and for Medical Care 46
- Predictions of the Grossman Model 50
- A Reduction in the Price of Medical Care 50
- An Increase in the Individual’s Wage Rate 51
- An Increase in the Individual’s Age 51
- An Increase in the Individual’s Educational Attainment 51
- 2.4 Measuring Health Capital 54
- Mortality 54
- Quality-of-Life Rating Scales 55
- Quality of Life Derived from Trade-off Questions 56
- 2.5 Adding Uncertainty: Decision Trees, Backward Induction, and Decision Making under Uncertainty 57
- A Realistic Application: A Pediatrician’s Decision about Ordering a Throat Culture 58
- Errors in Diagnostic Tests 60
- 2.6 Consumer Choices about Health Behaviors: A General Framework 61
- Unhealthy Behaviors 61
- The Concept of Present Value 62
- Fundamental Underlying Assumptions 62
- Assumptions: Rational, Forward-Looking, and Time Consistency Described 62
- Ex Ante Expectations and Decisions, Ex Post Realizations, and Revising Expectations from Learning 64
- Is the Economic Framework of Health Behavior Decision Making Plausible? 65
- Economic Evidence on Health Behaviors and Public Policy Implications 66
- 2.7 Frontier Issues: The Behavioral Economics Critique—Theory and Evidence 67
- 2.8 Summary and Conclusions 69
- Key Concepts 70
- Review and Discussion Questions 70
- Exercises 71
- Online Supplemental Material 75
- Supplemental Readings 76
- 2A Application to Decision to Start and Stop Smoking 76
- References 80
- Chapter 3 Demand for Health Care Services 83
- 3.1 Basic Economic Concepts of Demand 85
- 3.2 Demand in the Context of Health Insurance Coverage 87
- 3.3 The Concept of Time Price 95
- 3.4 Empirical Studies of Demand 97
- Data Used in Demand Studies 97
- Observational Data 97
- Randomized Controlled Trials 98
- Natural Experiments 99
- The RAND Health Insurance Experiment 100
- The Research Issues 100
- HIE Study Design 101
- HIE Results 102
- Effects of Deductibles 108
- Cost Sharing: Greater Effect on Demand for Low-Income Than High- Income Families? 108
- Income Effects on Demand for Care 109
- Effects of Capitation on Use of Services 111
- Other Empirical Evidence on the Effect of Price on the Quantity Demanded 113
- Empirical Evidence on the Effects of Health Insurance on Demand in a Low- Income Country 114
- 3.5 Welfare Analysis 115
- 3.6 Other Determinants of Demand for Personal Health Care Services 118
- 3.7 Summary and Conclusions 119
- Key Concepts 120
- Review and Discussion Questions 121
- Exercises 121
- Online Supplemental Material 124
- Supplemental Readings 125
- References 125
- Chapter 4 Demand for Private Health Insurance 127
- 4.1 Relationships among Health, Health Insurance, and the Use of Personal Health Care Services 128
- 4.2 Insurance Concepts and Terminology 130
- First-Party and Third-Party Insurance 130
- Pecuniary and Nonpecuniary Loss 131
- The Price of Insurance 131
- 4.3 Diminishing Marginal Utility of Wealth and the Demand for Insurance 133
- Utility of Wealth 133
- Expected Utility 134
- 4.4 Model of Demand for Insurance 136
- The Basic Model 136
- Effects of Shifts in the Utility Function, Changes in Θ, and in Changes in
- L on the Decision to Purchase Insurance 138
- Shifts in the Utility Function 138
- Change in Probability of Incurring a Loss (Becoming Sick) 139
- Change in the Magnitude of the Loss Conditional on a Loss (Becoming Sick) 139
- The Risk-Lover Case 139
- Implications of Theory: Determinants of Demand for Insurance 140
- The Premium of a Health Insurance Policy 142
- 4.5 Empirical Issues 142
- Why Do the Probability and Magnitude of the Loss Vary? 142
- Why Income Affects Demand for Insurance 143
- 4.6 Health Insurance and Welfare: The Deadweight Loss of Excess Insurance Revisited 144
- 4.7 Role of Tax Subsidies in Demand for Health Insurance 145
- 4.8 Adverse Selection 147
- How Adverse Selection May Arise in Health Insurance Markets 147
- Adverse Selection and Unraveling in Insurance Markets 150
- Adverse Selection and Unraveling: The Case of Harvard University 155
- Empirical Evidence on Adverse Selection in Private Health Insurance Markets 157
- 4.9 “Risk Adjustment” and Adverse and Preferred Risk Selection 161
- 4.10 Summary and Conclusions 162
- Key Concepts 163
- Review and Discussion Questions 164
- Exercises 165
- Online Supplemental Material 166
- Supplemental Readings 166
- References 167
- Part II Supply of Health Care Services and Insurance 169
- Chapter 5 The Market for Physicians’ Services 171
- 5.1 Medical School Capacity and Concepts of Physician Shortage and Surplus 172
- 5.2 Physician Supply in the Long Run 174
- Choice of Medicine as a Career 174
- Physician Choice of Specialty 178
- Concept of Present Value 179
- Concept of Internal rate of Return 180
- Physician Geographic Location Decisions 184
- The Economics of Physician Group Practice 185
- Economies of Scale and Scope 185
- Referrals 186
- Coverage of Patients 186
- Reduction in Earnings Fluctuations 186
- Empirical Evidence 187
- 5.3 Physicians’ Short-Run Decisions 188
- Overview 188
- Reconciling Stylized Facts of the Physicians’ Services Market with Standard Economic Models 192
- Why the Demand Curve Facing the Individual Physician May Be Downward Sloping 192
- Why Are Physicians’ Fees Often Higher in Markets with More Physicians? 193
- Practice Input Price Differences 193
- The Pauly-Satterthwaite Model 195
- The Quality-Amenities Model 195
- Summing Up 196
- Reconciling Stylized Facts of the Physicians’ Services Market with Standard Economic Models: Fees Set Administratively 197
- Quantity Increases with Administered Price Decreases 197
- Backward-Bending Supply Curve of Physicians 197
- Other Empirical Evidence on the Effects of Administered Price Reductions on Volume of Physician Services 199
- Summing Up 199
- Reconciling Stylized Facts of the Physicians’ Services Market: Other Models 200
- Target Income and Supplier-Induced Demand 200
- Empirical Findings on TI and PID 202
- Public Policy Implications If PID Is Supported by Empirical Evidence 203
- 5.4 Price Discrimination 204
- Background 204
- Theory 205
- Empirical Evidence 208
- 5.5 Summary and Conclusions 210
- Key Concepts 211
- Review and Discussion Questions 211
- Exercises 213
- Online Supplemental Material 216
- Supplemental Readings 216
- References 216
- Chapter 6 Hospitals 219
- 6.1 Context 220
- 6.2 Alternative Models of Hospital Behavior 221
- The Profit-Maximizing Hospital: The Base Case 221
- A Model of a Private Not-for-Profit Hospital 224
- The Model’s Basics 224
- Effects of Exogenous Changes in Wage Rates, Population Size, Fraction of Persons with Health Insurance Coverage, and Subsidies of Hospitals 228
- The Pauly-Redisch Model of the Not-for-Profit Hospital as a Physicians’ Cooperative 228
- Physician-Hospital Organizations 236
- Summing Up 237
- 6.3 Hospital Ownership and Performance 238
- Why Are For-Profit Hospitals a Minority? 238
- Fiduciary Relationships and Complex Output 238
- Noncontractible Quality 239
- Public Goods 240
- Implicit Subsidies 240
- Explicit Subsidies 241
- Cartels 241
- Low Profits 241
- Empirical Evidence on Hospital Ownership and Performance 241
- Allegations against For-Profit Hospitals 241
- Empirical Analysis of the Effects of Ownership on Hospital Performance 243
- Reviews of the Literature on the Effects of Ownership on Hospital Performance 244
- 6.4 Regulation of Hospitals 245
- Context 245
- Retrospective Cost Reimbursement 247
- Regulatory Responses 249
- Entry Regulation 250
- Price-Revenue Regulation and Prospective Payment 254
- 6.5 An Alternative to Regulating Hospitals: Increasing Competition among Hospitals 259
- Description 259
- Empirical Evidence on the Effects of Competition under the New Regime 260
- Empirical Evidence on the Effects of Increased Competition on Hospital Quality 263
- 6.6 Summary and Conclusions 264
- Key Concepts 265
- Review and Discussion Questions 265
- Exercises 266
- Online Supplemental Material 269
- Supplemental Readings 270
- References 270
- Chapter 7 Quality of Care and Medical Malpractice 275
- 7.1 Markets and Market Failure 275
- 7.2 Characteristics of Health Care Quality 279
- How Economists View Quality 279
- How the Quality of Personal Health Care Services Is Measured 280
- 7.3 Adverse Events and Negligent Injuries 283
- The Issues 283
- How the Estimates of Adverse Outcomes Were Generated 283
- The Quality of the Estimates 284
- Do Observed Rates of Medical Errors and Adverse Outcomes Represent a Market Failure Justifying Government or Other Intervention? 285
- 7.4 Supply-Side Quality-of-Care Safeguards and Government Oversight and Regulation 286
- Overview 286
- Professional Norms 286
- Peer Review 287
- Licensure 287
- Certification 288
- 7.5 Mandatory Error Reporting 288
- Description 288
- Implications 290
- 7.6 Tort Law as a Mechanism for Improving Patient Safety and Health Care Quality 291
- Why Other Quality Assurance Mechanisms May Fail 291
- The ABCs of Tort Law 292
- Tort Law Defined 292
- The Socially Optimal Injury Rate 293
- The Negligence Rule: Only One of Several Alternative Liability Rules 295
- Contracts versus Torts 296
- When the Negligence Rule Leads Private Parties to Select a Socially Optimal Precaution Level 298
- Tort Liability under Attack 298
- 7.7 Medical Malpractice 299
- Overview 299
- Medical Care Market 300
- Legal Market 302
- 7.8 Does the Threat of Medical Malpractice Suits Deter Iatrogenic Injuries? 303
- 7.9 Summary and Conclusions 308
- Key Concepts 309
- Review and Discussion Questions 309
- Exercises 310
- Online Supplemental Material 312
- Supplemental Readings 313
- References 314
- Chapter 8 Nurses in Hospital and Long-Term Care Service 319
- 8.1 Labor Markets for Nurses Worldwide 320
- 8.2 Supply of Nurses: Too Many or Too Few? 325
- Economic Concepts of Surplus and Shortage 325
- Role of Public Regulation 329
- Role of Monopsony Power 334
- 8.3 Empirical Estimates of Nurses’ Response to a Wage Change 338
- 8.4 Nonwage Determinants of the Nurse Labor Supply 343
- 8.5 Nurses in the Production of Hospital Services 344
- Do Higher Nurse-to-Patient Ratios Improve the Quality of Hospital Care? 344
- Public Policy Responses 349
- 8.6 Nurses in the Production of Nursing Home Services 352
- Overview 352
- Effects of Economic Factors on Nurse Staffing and Mix 353
- Effects of Nurse Staffing Levels and Mix on Patient Outcomes 355
- Implications for Public Policy 355
- 8.7 Summary and Conclusions 357
- Key Concepts 358
- Review and Discussion Questions 358
- Exercises 359
- Online Supplemental Material 362
- Supplemental Readings 362
- References 363
- Chapter 9 Pharmaceutical manufacturers 367
- 9.1 Companies’ Decisions about Investments in R&D 368
- Basic Facts of the Pharmaceutical R&D Process 368
- The Optimal Investment Decision from a Pharmaceutical Company’s Vantage Point 370
- Incentives for Pharmaceutical Innovation 371
- Pull Incentives 371
- Push Incentives 372
- Combination of Pull and Push Incentives 375
- Disincentives for Pharmaceutical Innovation 376
- 9.2 Pricing of New Drugs 379
- Rationale for Patents and Public Policy Trade-offs 379
- Pricing New Drugs: Empirical Evidence 382
- 9.3 Entry of Generic Drugs and Its Consequences 384
- Competition between Generic and Brand-Name Drugs 384
- Factors Affecting Generic Competition 386
- Consequences of Generic Competition 388
- 9.4 Advertising 389
- Companies’ Incentives to Allocate Funds to Marketing 390
- Composition of Pharmaceutical Company Marketing 392
- Detailing and Its Effects 393
- Direct-to-Consumer Advertising and Its Effects 393
- 9.5 International Pricing 394
- Cross-National Price Differentials 394
- The Consequences of Differential Pricing 396
- Ramsey Optimal Pricing 398
- Empirical Evidence on Ramsey Pricing of Pharmaceuticals 399
- 9.6 Developing New Drugs: Rare Diseases and Diseases Prevalent in Low- Income Countries 401
- Rewards as a Substitute for Patents: Overview 401
- Specific Proposals 403
- Advance Purchase Commitments 403
- Optional Rewards Based on Therapeutic Effect 404
- Priority Review Voucher 406
- 9.7 Summary and Conclusions 406
- Key Concepts 408
- Review and Discussion Questions 408
- Exercises 410
- Online Supplemental Material 412
- Supplemental Readings 412
- References 413
- Chapter 10 The Supply of Private Health Insurance 417
- 10.1 The ABCs of the Business of Insurance 418
- Functions of Insurers 418
- Risk Bearing 418
- Marketing and Underwriting 419
- Claims Processing 420
- Loss Prevention 421
- Measuring the Financial Strength of Insurers: An Insurer’s Income Statement and Balance Sheet 421
- Income Statement 421
- Balance Sheet 422
- Insurerers’ Cash Flow, Income from Investments, and Premium Setting 422
- Timing of Insurers’ Revenue and Expenses 422
- Investment Income 423
- Higher Investment Income Leads to Lower Premiums on the Underwriting Side of an Insurer’s Business 423
- Reinsurance 424
- Underwriting Cycles 425
- 10.2 Are Insurers’ Premiums and Returns Excessive? 425
- 10.3 Private versus Public Provision of Health Insurance Coverage 427
- The Case for and against Relying on Private Health Insurance for Provision of Coverage to a Population 429
- 10.4 Employer-Based Private Health Insurance Coverage 432
- Advantages of Employer-Based Coverage 432
- Who Really Pays for Employer-Based Health Insurance Coverage? 434
- 10.5 Government Regulation of Private Health Insurance 437
- Rationale for Government Regulation 437
- Insurance Mandates: A Form of Private Regulation of Private Health Insurance 439
- Community Rating 443
- Managed Care Defined 445
- The Effect of Managed Care on Market Structure and Providers’ and Patients’ Incentives 448
- Managed Care and Health System Performance 451
- Overview 451
- Effects of Managed Care on Spending on Personal Health Care 451
- Effects of Managed Care on Diffusion of Technology 453
- The Backlash against Managed Care 456
- Private Health Insurance and Universal Health Insurance Coverage 456
- 10.6 Summary and Conclusions 457
- Key Concepts 459
- Review and Discussion Questions 459
- Exercises 460
- Online Supplemental Reading 462
- Supplemental Readings 462
- References 463
- Part III Market Structure in the Health Care Sector 467
- Chapter 11 Private Financing of Health Care Services 469
- 11.1 Rationale for Health Systems Analysis 470
- 11.2 Classification of Health Care Systems 474
- 11.3 Cash Systems 484
- Overview 484
- The Indian Health Care System 485
- The Chinese Health Care System 486
- 11.4 The Private System: The US Experience 491
- Base Case: Private Provision and No Insurance Coverage 491
- Evolution of Private Health Insurance in the 1930s and 1940s 491
- 11.5 The Managed Competition Model 491
- 11.6 Comparisons between Single- and Multiple-Payer Systems 494
- Cost Shifting 494
- Patient Selection 495
- Spillover Effects 496
- 11.7 Summary and Conclusions 496
- Key Concepts 498
- Review and Discussion Questions 498
- Exercises 498
- Online Supplemental Readings 500
- Supplemental Readings 500
- References 501
- Chapter 12 Government Financing and Private Supply 503
- 12.1 The Role of Government as a Payer: Rationale for the Public Provision of Health Insurance 504
- Universal Coverage, Social Insurance, and Means-Tested Insurance 504
- Arguments of Advocates for the Public Provision of Health Insurance 505
- Choices in the Design of Public Payment Systems 508
- 12.2 Evolution and Structure of the Payment System: German Statutory Health Insurance 514
- 12.3 Evolution and Structure of the Payment System: The US Medicare Program 516
- Background 516
- Hospital Payment under Medicare: The Medicare Prospective Payment System 519
- Physician Payment under Medicare: Fixed Fees Based on a Resource- Based Relative Value Scale 522
- Effects of Medicare 524
- Technological Change 524
- Population Subgroups 525
- Population Health 526
- 12.4 Evolution of Payment Systems: The US Medicaid Program 528
- Background 528
- Choice of Medicaid Benefits versus Self-Insurance versus Private Insurance 528
- Empirical Evidence on Medicaid Fee Schedule 532
- Medicaid and Nursing Home Care 533
- 12.5 Evolution of Payment Systems: Canada’s Medicare 534
- Background 534
- Effects of the Canadian Medicare Program 535
- Patient Waiting Time to Receipt of Care 535
- Use of Costly Procedures 536
- Disparities in Health and in the Use of Services 536
- 12.6 Evolution of Payment Systems in Asian Countries on the Pacific Rim 536
- Background 536
- Japan 537
- South Korea 539
- Taiwan 540
- Effects of Universal Health Insurance 542
- 12.7 The Public Health Insurance Program in Rural China 545
- Background 545
- Effects of the NCMS 546
- 12.8 Discussion and Conclusions 549
- Key Concepts 551
- Review and Discussion Questions 551
- Exercises 553
- Online Supplemental Material 556
- Supplemental Readings 557
- References 557
- Chapter 13 Public Supply and Financing 563
- 13.1 The Rationale for Public Provision of Health Care 564
- The Role of Transaction Costs 564
- Noncontractible Outcomes Revisited 565
- Redistributive Concerns 569
- 13.2 Public Provision in High-Income Countries in Practice 572
- The United Kingdom's National Health Service 572
- Overview 572
- Rationing by Queues Rather Than by Prices 573
- Non-price Rationing: Pros and Cons 574
- Empirical Evidence on the Costs of Waiting Lists 579
- The NHS Internal Market 583
- Australia 585
- Overview 585
- Empirical Evidence 586
- 13.3 Public Provision of Personal Health Care Services in Other Countries 587
- High-Income Countries 587
- Middle- and Low-Income Countries 587
- Dominance of Public Ownership Form 587
- Evidence on Quality of Care 588
- Public Policy Options for Improving Quality of Care 590
- Empirical Evidence on Effects of Interventions to Improve Quality of Care 591
- 13.4 Evaluation and Comparison of Health Care Systems 593
- Comparisons Based on Intermediate Performance Measures 593
- Access 593
- Cost 595
- Quality 599
- Comparisons Based on Two Performance Goals 600
- Efficiency 600
- Equity 601
- 13.5 Summary 603
- Key Concepts 605
- Review and Discussion Questions 605
- Exercises 606
- Online Supplemental Material 608
- Supplemental Readings 609
- References 610
- Part IV Performance of the Health Care Sector: Positive and Normative Aspects 615
- Chapter 14 Cost and Cost-Effectiveness Analysis 617
- 14.1 Overview of Cost-Effectiveness and Cost-Benefit Analysis 618
- 14.2 Cost-Effectiveness Analysis: Measuring Cost 622
- Overview 622
- Concept of Opportunity Cost 622
- Direct and Indirect Costs 623
- Other Cost Concepts 624
- Transfer Costs 624
- Future Costs 624
- Sunk versus Incremental Costs 625
- Joint Costs/Joint Production 625
- Cost from Alternative Perspectives 626
- 14.3 Cost-Effectiveness Analysis: Measuring Effectiveness 627
- Effectiveness versus Efficacy 627
- Endpoints 628
- Evaluating the Marginal Effect of Specific Technologies 632
- Goal of Evaluation 632
- Transition Probabilities 633
- Markov Chains 633
- Obtaining Transition Probabilities from Observational Data 634
- Discounting 636
- Rationale for Discounting 636
- Determining the Appropriate Discount Rate: Financial versus Health Discount Rates 637
- Computing a Cost-Effectiveness Ratio 639
- 14.4 Applications of Cost-Effectiveness Analysis 640
- Disease Prevention 640
- The Experience of a US State, Oregon 640
- Cost-Effectiveness of Thrombolytic Therapy for Acute Myocardial Infarction 641
- Cost-Effectiveness of HIV Treatment in Low-Income Settings 643
- Cost-Effectiveness of Screening for Cervical Cancer in Low-Income Settings 648
- 14.5 Use of Economic Evaluation in Practice: Conclusions and Implications 650
- Key Concepts 652
- Review and Discussion Questions 652
- Exercises 653
- Online Supplemental Material 654
- Supplemental Readings 655
- References 655
- Chapter 15 Measuring Benefits and Cost-Benefit Analysis 657
- 15.1 Measuring Benefits in Cost-Benefit Analysis: A Review 658
- 15.2 The Revealed Preference Approach 660
- Objective 660
- Underlying Assumptions 661
- Evidence from Labor Markets 661
- Value of a Statistical Life 665
- An Application of the Revealed Preference Approach: Cigarette Smokers as Job Risk Takers 666
- 15.3 The Stated Preference Approach 669
- Contingent Valuation 669
- Stated Choice or Attribute-Based Methods 671
- Contingent Behavior or Contingent Activity Questions 671
- Assessing the Validity of Stated Preference Measures 671
- Stated Preference Method Application 1 672
- Stated Preference Method Application 2 674
- Theory: Risk-Dollar Trade-offs 674
- Theory: Risk-Risk Trade-offs 675
- Surveys of WTP to Avoid Intangible Loss of Multiple Sclerosis 675
- Results 677
- Implications 678
- Stated Preference Application 3: Benefits and Costs of Cholera Vaccination 679
- Background and Study Rationale 679
- Program Benefit and Cost 679
- Measuring Private Benefit to the Vaccinated 680
- Use of Stated Preference Method to Measure Vaccine Demand 680
- Measuring Private Benefit to the Unvaccinated 681
- Measuring Savings in Public Health Expenditures Attributable to the Vaccine Program 682
- Some Key Findings 682
- 15.4 Use of Cost-Benefit and Cost-Effectiveness Analysis in Public Decision Making 683
- 15.5 Conclusions 686
- Key Concepts 686
- Review and Discussion Questions 687
- Exercises 688
- Online Supplemental Material 689
- Supplemental Readings 690
- References 690
- Chapter 16 The Contribution of Personal Health Services to Longevity, Population Health, and Economic Growth 693
- 16.1 The Link between Health and Economic Sectors 694
- Overview 694
- The Relationship between Improved Health and Longevity and Economic Growth 697
- 16.2 Effects of Health Care Financing on National Economies 698
- Savings Behavior 698
- Labor Market Outcomes 699
- Welfare Loss of Taxation 701
- 16.3 Secular Trends in Determinants of Health Inputs and Outputs 704
- Secular Trends in Expenditures on Personal Health Care Services 704
- Determinants of Personal Health Care Expenditures 706
- Secular Trends in Health Outcomes 709
- Determinants of Mortality 709
- 16.4 Contributions of Personal Health Care Services to Improved Population Health 710
- Conceptual Framework 710
- Empirical Evidence from Cross-Sectional Studies 712
- Overview of Analytic Approaches 715
- The Disease Approach 715
- The Proxy Variable Approach 717
- The Accounting Method 719
- 16.5 Contribution of Improved Health to Economic Growth 720
- Direct Effect on Productivity 720
- Indirect Effects Operating through Fertility, Education, and Saving 721
- Other Indirect Effects 723
- Contested Issues 723
- 16.6 The Health Sector as a Job Machine 725
- 16.7 Economic Growth and Disease Patterns 726
- 16.8 Summary and Conclusions 728
- Key Concepts 729
- Review and Discussion Questions 729
- Exercises 731
- Online Supplemental Material 732
- Supplemental Readings 732
- References 732
- Chapter 17 Frontiers of Health Economics 737
- 17.1 Rational versus Irrational Decision Making in Health Care 737
- 17.2 Information, Asymmetric Information, and Its Effects 740
- How People Obtain Information 740
- 17.3 Industrial Organization of the Health Care Sector 743
- Principal-Agent Issues: Physicians 743
- Pay for Performance 744
- Competition among Hospitals 745
- 17.4 Competition versus Public Regulation versus Public Ownership in Health Care 746
- 17.5 Clinical Decision Making 747
- 17.6 Final Word 748
- Key Concepts 749
- Review and Discussion Questions 749
- Supplemental Readings 750
- References 750
- Index 753
Endorsements
"Health Economics is Sloan and Hsieh's magnum opus, in which they share with readers their exceptionally broad and rich understanding of all aspects of the field. There are very few people who could have written this book, and among them very few who would have been willing to expend the time and effort to synthesize decades of research and make it all clear and accessible. This textbook is a gift to the next generation of health economists."
John Cawley, Professor of Policy Analysis and Management, Professor of Economics, and Co-Director of the Institute on Health Economics, Health Behaviors and Disparities, Cornell University
"Sloan and Hsieh fluidly integrate the basic insights from economics into the study of health care and health care financing, while incorporating new developments in medical decision-making analysis and behavioral economics. Many students in the U.S. come to health economics with an interest in global health issues, and they will see here international application of the main principles. An excellent first textbook in health economics."
Thomas McGuire, Department of Health Care Policy, Harvard Medical School
"This comprehensive book covers virtually every aspect of health economics. The book can be used in a highly successful manner in courses for undergraduate economics majors and minors, as well in those for undergraduates and graduate students with little background in the discipline. Moreover, given its wide-ranging discussions of practically all of the recent literature, it is a key supplementary text for graduate courses in health economics. Bravo for this tour de force of the field!"
Michael Grossman, Distinguished Professor of Economics, City University of New York Graduate Center; Health Economics Program Director, National Bureau of Economic Research
"Health Economics is likely to be the new standard. The exposition is accessible and engaging. The economic content is deep as well as broad, and will serve the needs of both advanced students and economics novices."
John A. Romley, Price School of Public Policy, University of Southern California; Economist, Leonard D. Schaeffer Center for Health Policy and Economics; Managing Editor, Forum for Health Economics & Policy
